U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT06971965) titled 'Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.' on April 27.
Brief Summary: This study is a multicenter randomized controlled trial conducted in Korea. A parallel, two-group randomized design will be with thyroid stimulating hormone suppression therapy group(low TSH group; intervention) is different from the wIthout thyroid stimulating hormone (TSH) suppression therapy group(high TSH group; control).
Study Start Date: June 02
Study Type: INTERVENTIONAL
Condition:
Thyroid Cancer
Papillary Thyroid Carcinoma
Intervention:
DRUG: Levothyroxin
During the five-year study intervention period, ...